Absci Announces Research Collaboration with Merck

Absci Announces Research Collaboration with Merck

Collaboration to leverage Absci’s Deep Learning-Enabled Drug Creation™ and Bionic Protein™ technologies VANCOUVER, Wash., Jan. 07, 2022 (GLOBE NEWSWIRE) — Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and...
FibreCoat closes first financing round

FibreCoat closes first financing round

(Aachen) 17.11.2021—FibreCoat GmbH, an innovative composite materials spin-off from the Institut für Textiltechnik (ITA) of RWTH Aachen University, announces it closed a $3 million Series A round with Goose Capital, Phoenix Venture Partners, b.value AG, NOVA by...